Article

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial

2021-06-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objectives</h4> To compare the co-administration of an Ayurvedic drug AYUSH 64 as an adjunct to standard of care (SOC) and SOC for efficacy and safety in the management of COVID-19. <h4>Design</h4> Multicentre, parallel efficacy, randomized, controlled, open label, assessor blind, exploratory trial with a convenience sample. Patients followed to complete 12 weeks of study duration. <h4>Settin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 31330fc7-6c99-5f07-82eb-59bdf9077062
DOI: 10.1101/2021.06.12.21258345

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trialDOI 10.1101/2021.06.12.21258345Read

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read

Evolution of COVID-19 patients treated with ImmunoFormulation, a combination of nutraceuticals to reduce symptomatology and improve prognosis: a multi-centred, retrospective cohort studySemantic proximity Read

Traditional Medicines Used as Adjuvant Therapy for COVID-19 Symptoms in Syria: An Ethno-medicine SurveySemantic proximity Read

A Prospective, controlled, pilot study of personalized add-on Ayurveda treatment in high-risk Type II Diabetes COVID-19 patientsSemantic proximity Read

Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19Semantic proximity Read

Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive EvaluationSemantic proximity Read

CoVAM: Complementary and Alternative Medicine Clinical Trials Database for COVID-19 DiseaseSemantic proximity Read

To Study the Effect of Unconventional Treatment Protocol on COVID-19 Patients in Delhi Using Artificial Intelligence Based Methods.Semantic proximity Read

Chinese Herbal Medicine (“3 Medicines and 3 Formulations”) for COVID-19: Rapid Systematic Review and Meta-AnalysisSemantic proximity Read

Botanical Drugs and Supplements Affecting the Immune Response in the Time of COVID-19: Implications for Research and Clinical PracticeSemantic proximity Read

Early suPAR-Guided Anakinra Treatment in COVID-19 Pneumonia: Subgroup Analyses and 90-Day Outcomes of the SAVE-MORE TrialSemantic proximity Read

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infectionSemantic proximity Read